Don’t forget CEO and directors have all paid around 8 cents for their shares that they get on May 16th. With GLP results due next month and straight into phase one they wouldn’t come in at a share price 10 percent lower than current share price. Should be trading at around 70 million heading into phase 1 with upside from Walter reed results which are already de risked from 2010 preclinical study and puts the partnership with the US army in the bag coming up for future funding. 5 million dollar EV funny
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.010(3.45%) |
Mkt cap ! $63.43M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 28.0¢ | $277.0K | 957.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 31270 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 130414 | 1 |
View Market Depth
| Last trade - 15.54pm 07/08/2025 (20 minute delay) ? |
| NYR (ASX) Chart |